Five years survival and risk of death in a phase III study of intermmittent monotherapy versus continuous combined androgen deprivation

Autor:	N. Antoniou, S. Pastidis, Robert Oliver, F.E. Calais da Silva, Peter Whelan, F. M. Calais da Silva, Ján Kliment, F. Gonçalves, Chris Robertson, M. Queimadelos, A. C. Santos
Rok vydání:	2008
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry medicine.drug_class fungi food and beverages Androgen Androgen deprivation therapy Endocrinology Internal medicine medicine Risk of death business
Zdroj:	Journal of Clinical Oncology. 26:16034-16034
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2008.26.15_suppl.16034
Popis:	16034 Background: Intermittent androgen deprivation therapy can only be appropriately evaluated in a randomized fashion, we propose this Phase III study comparing the intermittent monotherapy with ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f6965dfe878b49627f2c43516de98b53 https://doi.org/10.1200/jco.2008.26.15_suppl.16034 Zobrazit plný text záznamu